Bell Michael Brian 4
4 · Guardant Health, Inc. · Filed Mar 17, 2026
Research Summary
AI-generated summary of this filing
Guardant Health (GH) CFO Michael Bell Exercises RSUs and Sells Shares
What Happened
- Michael Brian Bell, Chief Financial Officer of Guardant Health, had restricted stock units (RSUs) vest on March 15, 2026, converting to 13,790 shares. To cover tax withholding, 7,413 shares were retained by the company (cashless/net-share settlement) and 3,000 shares were sold in the open market on March 16, 2026. The shares withheld for taxes generated $633,737; the open-market sale netted approximately $261,111 — total proceeds/withholdings of about $894,848.
Key Details
- Dates: RSU conversion/vesting reported 2026-03-15; open-market sale on 2026-03-16; Form 4 filed 2026-03-17 (filed timely).
- Share counts and values:
- 13,790 shares converted from RSUs (1,233 + 10,518 + 2,039).
- 7,413 shares withheld for tax obligations at $85.49/share = $633,737 (company retained).
- 3,000 shares sold in open market, weighted average $87.04/share (sales ranged $87.0001–$87.15) = $261,111.
- Shares owned after the transactions: not specified in the supplied filing extract.
- Footnotes of note:
- F1: Company retained shares solely to satisfy the employee’s tax withholding; amount not in excess of tax liability.
- F2: Weighted average sale price reported; multiple sale prices ranged $87.0001–$87.15.
- F3, F5, F6: The shares came from multiple RSU awards — a May 9, 2022 RSU award (staggered vesting), a June 7, 2023 performance-based RSU (second tranche achieved and vested 3/15/26), and a June 9, 2023 RSU award (quarterly vesting).
Context
- This was primarily a vesting of RSUs with a net-share settlement to cover taxes (common, routine for executives), followed by a small open-market sale. The mix of withheld shares and sales indicates a cashless/net settlement for tax obligations rather than a standalone buy/sell decision expressing market sentiment. The Form 4 was filed promptly.
Insider Transaction Report
Form 4
Bell Michael Brian
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2026-03-15+1,233→ 41,457 total - Exercise/Conversion
Common Stock
2026-03-15+10,518→ 51,975 total - Exercise/Conversion
Common Stock
2026-03-15+2,039→ 54,014 total - Tax Payment
Common Stock
[F1]2026-03-15$85.49/sh−7,413$633,737→ 46,601 total - Sale
Common Stock
[F2]2026-03-16$87.04/sh−3,000$261,111→ 43,601 total - Exercise/Conversion
Restricted Stock Units
[F3][F4]2026-03-15−1,233→ 0 totalExercise: $0.00→ Common Stock (1,233 underlying) - Exercise/Conversion
Performance-Based Restricted Stock Units
[F5][F4]2026-03-15−10,518→ 0 totalExercise: $0.00→ Common Stock (10,518 underlying) - Exercise/Conversion
Restricted Stock Units
[F6][F4]2026-03-15−2,039→ 2,039 totalExercise: $0.00→ Common Stock (2,039 underlying)
Footnotes (6)
- [F1]These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
- [F2]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $87.0001 to $87.1500. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]This represents a restricted stock unit award granted on May 9, 2022 that vested over a four-year period. 25% of the shares subject to such award vested on March 15, 2023 and the remaining 75% of the shares vested in equal quarterly installments over the remaining three-year period thereafter.
- [F4]Not applicable for Restricted Stock Units.
- [F5]This represents a performance-based restricted stock unit award granted on June 7, 2023 with a 3-year performance metric. The second tranche metric was achieved and the shares vested on March 15, 2026.
- [F6]This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
Signature
/s/ John G. Saia, as attorney-in-fact for Michael Brian Bell|2026-03-17